TEAD2 and cancer: The inclusion of a 12-nucleotide exon in TEAD2 (event ID: HsaEX0064372) is one of the most consistently decreased microexons in tumors (6/9 tissue types in our dataset; S12A Fig) and is SRRM4 regulated, as evidenced by its up-regulation in all 6 cancer cell lines after SRRM4 overexpression (S12B and S12C Fig).